RT Journal Article
SR Electronic
T1 WITHDRAWN: Genomic characterization of Crimean-Congo Hemorrhagic Fever Virus detected during nosocomial outbreak (2023) in Balochistan province of Pakistan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.28.23299125
DO 10.1101/2023.11.28.23299125
A1 Umair, Massab
A1 Haider, Syed Adnan
A1 Ali, Qasim
A1 Hakim, Rabia
A1 Raisani, Maqbool Ahmed
A1 Ayub, Adnan
A1 Salman, Muhammad
YR 2023
UL http://medrxiv.org/content/early/2023/12/11/2023.11.28.23299125.abstract
AB The authors have withdrawn their manuscript owing to lack of approval by provincial health authorities to publish this work. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe gratefully acknowledge the New Variant Assessment Platform (NVAP), UK Health Security Agency (UKHSA) for their support of sequencing reagents.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Internal Review Board of the National Institute of Health (NIH), Islamabad, Pakistan. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes